New research from @DanaFarber’s @SarahJHill6 reveals that as CDK4/6 inhibitors are being investigated as a possible treatment in endometrial cancer, RB function-predictive transcriptional signatures may be a relevant biomarker to help predict response to therapy.
➡️https://t.co/8Iu1STIRtZ
Read our latest: Dysregulation of the ORigin FIring Under Stress (ORFIUS) complex may promote high grade serous ovarian cancer survival after DNA damage. From the Sarah J. Hill lab @DanaFarber https://t.co/7kAhvmUugp
"To have the honor of holding the Livingston chair, the selected scientist will need to reach a high bar in multiple areas, including being an extraordinary mentor, a scientific visionary, a supportive colleague and a bridge builder." https://t.co/FC9MVAi0Pt
Congratulations to the AACR NextGen Stars, including Sarah J. Hill, MD, PhD (@SarahJHill6)👏🎉
Tune in to Dr. Hill's presentation on April 11: https://t.co/QTUa4iZv68 #AACR22#OvarianCancer#GynCSM
Congrats to Sarah Hill, MD, PhD (@SarahJHill6), winner of the @AACR Cancer Research Early Career Award! Dr. Hill is being recognized for the significant impact she has made in the field of #ovariancancer research. Learn more about Dr. Hill’s work: https://t.co/ORBwqYS6ct #AACR21